Michael Peterson
Family Medicine · Jacksonville, FLNPI 1184037020
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for family medicine clinicians in FL, where the typical reported total is $424.
Across 28 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$93
- Amgen$74
- AstraZeneca$69
- Pfizer$52
- Merck$42
- Medtronic$30
- plus $69 from 4 others
What the payments were for
- Food & beverage$431100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $93 |
| Amgen | 3 | $74 |
| AstraZeneca | 5 | $69 |
| Pfizer | 4 | $52 |
| Merck | 3 | $42 |
| Medtronic | 2 | $30 |
| Lilly USA, LLC | 2 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$431 in reported general payments places this provider in the 50th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 16 | $28,573 |
| Gabapentin | 29 | $452 |
| Atorvastatin Calcium | 62 | $329 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $286 |
| Amlodipine Besylate | 57 | $270 |
| Tamsulosin Hcl | 21 | $262 |
| Rosuvastatin Calcium | 11 | $217 |
| Lisinopril | 47 | $194 |
| Omeprazole | 24 | $177 |
| Metformin Hcl | 20 | $145 |
| Escitalopram Oxalate | 11 | $145 |
| Metronidazole | 11 | $141 |
| Losartan Potassium | 20 | $141 |
| Carvedilol | 19 | $122 |
| Pantoprazole Sodium | 16 | $120 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jacksonville
- Colin LacroixJacksonville$93K
- Sarfaraz DhanjiJacksonville$58K
- Victor MicolucciJacksonville$29K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.